OMERS Administration Corp’s Integra LifeSciences IART Stock Holding History

OMERS Administration Corp’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-34,931	Closed	-$962K	–	441
2015 Q2	$962K	Buy	+34,931	New	+$931K	0.04%	267

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMERS Administration Corp's IART Position: Q3 2015 in Review

OMERS Administration Corp sold out of Integra LifeSciences (IART) in Q3 2015, closing a stake of 34,931 shares — an estimated $962K sold.

OMERS Administration Corp first reported a position in IART in Q2 2015 and held it in 1 quarter. The position peaked at $962K in Q2 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

OMERS Administration Corp reported no remaining Integra LifeSciences position as of Q3 2015 after selling out during the quarter.
OMERS Administration Corp sold 34,931 Integra LifeSciences shares in Q3 2015, an estimated $962K.
OMERS Administration Corp first reported a position in Integra LifeSciences in Q2 2015 and held it in 1 quarter.
OMERS Administration Corp's Integra LifeSciences position peaked at $962K in Q2 2015.
189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on OMERS Administration Corp's 13F filing for Q3 2015, filed 12 Nov 2015.